Abstracts tagged "magnetic resonance imaging (MRI) and synovitis"

Abstract Number: 287 • 2016 ACR/ARHP Annual Meeting
WITHDRAWN
Abstract Number: 2360 • 2016 ACR/ARHP Annual Meeting
The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study
Mohamed Jarraya¹, Ali Guermazi², David T. Felson³, Frank Roemer⁴, Michael C. Nevitt⁵, James Torner⁶, Cora E. Lewis⁷ and Joshua Stefanik⁸, ¹Mercy Catholic Medical Center, Darby, PA, ²Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁴University of Erlangen-Nuremberg, Erlangen, Germany, ⁵Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁶University of Iowa, UIowa, Iowa City, IA, ⁷Preventive Medicine, University of Alabama at Birmingham, Birmingham City, AL, ⁸Physical Therapy, Northeastern University, Boston, MA
Background/Purpose: To determine the relation of superolateral HoffaÕs fat pad (SHFP) edema and Hoffa-synovitis to cartilage damage and bone marrow lesions (BMLs) in the patellofemoral…
Abstract Number: 1302 • 2015 ACR/ARHP Annual Meeting
Inflammation Signs on Magnetic Resonance Imaging in Chronic or Recurrent Gonarthritis Treated with Intra-Articular Infliximab or Corticosteroids
Gülsah Akdemir¹, Arie E. van der Bijl², Badelog J.E. de Lange-Brokaar³, T. W. J. Huizinga¹, Cornelia F. Allaart¹ and Margreet Kloppenburg³, ¹Rheumatology, LUMC, Leiden, Netherlands, ²Isala Klinieken, Zwolle, Netherlands, ³Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: To evaluate synovial inflammation on magnetic resonance imaging (MRI) before treatment and changes after treatment with intra-articular (i.a.) infliximab (IFX) or methylprednisolone (MP) injections…
Abstract Number: 1017 • 2012 ACR/ARHP Annual Meeting
Bye Bye Biopsy: Diffusion Tensor and Dynamic Contrast Enhance Magnetic Resonance Imaging Parameters Reflect Molecular Events of Inflammation in the Synovium
Vikas Agarwal¹, Rishi Awasthi², Deepak Tripathi³, Vinita Agrawal⁴, Ram Kishore Singh Rathore⁵, Kusum Sharma⁶, CM Pandey⁷ and Rakesh K. Gupta⁸, ¹Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ²Radiodiagnosis, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India,, Lucknow, India, ³Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, India, ⁴Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, India, ⁵Mathematics and statistics, Indian Institute of Technology, Kanpur, India, ⁶Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁷Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, India, ⁸Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, India
Background/Purpose: Chronic synovial inflammation is characterized by accumulation of inflammatory cells and increased vascularity. Synovial histology remains the most definitive way to delineate the severity…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].